Aller au contenu principal
Profil bibliographique

Amelia Bhatnagar

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

27Publications signalées
335Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Antibiotic Resistance in BacteriaBacterial Identification and Susceptibility TestingAntibiotic Use and ResistancePharmaceutical and Antibiotic Environmental ImpactsAntibiotics Pharmacokinetics and Efficacy

Les publications récentes

Accès ouvert 2026 article OpenAlex

Comparison of laboratory-developed methods for aztreonam plus ceftazidime-avibactam antimicrobial susceptibility testing for metallo-beta-lactamase-producing Enterobacterales

Amelia Bhatnagar, Harley Harris, Emily Jacobs, Porscha Bumpus-White et autres

Metallo-beta-lactamase (MBL)-producing Enterobacterales are a global public health concern. Infections caused by these pathogens are often hard to treat, with few effective agents currently available. While aztreonam-avibactam only recently gained U.S. and European regulatory approval, laboratories have implemented laboratory-developed tests (LDTs) using …

Ouganda, us, ca (code pays fourni par la source)

0 citations Journal of Clinical Microbiology
Accès ouvert 2025 preprint OpenAlex

Evaluation of Enterobacterales carrying Acinetobacter -associated bla OXA genes—United States, 2017–2022

Giulia Orazi, Alyssa G. Kent, Nadine Wilmott, Desbelet Berhe et autres

Abstract Through their ability to hydrolyze carbapenems, Ambler class D beta-lactamases endanger patients by limiting the clinical efficacy of beta-lactam antimicrobials. Further, plasmid-mediated transmission can increase mobility of carbapenemase genes between bacteria and facilitate their spread between patients. In the United States …

us, pr (code pays fourni par la source)

0 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2024 article OpenAlex

Characterization of carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa carrying multiple carbapenemase genes—Antimicrobial Resistance Laboratory Network, 2018–2022

Sarah Sabour, Kristin R V Harrington, Ellen O. Martinson, Amelia Bhatnagar et autres

ABSTRACT Carbapenem-resistant Enterobacterales (CRE) and carbapenem-resistant Pseudomonas aeruginosa (CRPA) are significant public health threats, particularly when harboring carbapenemases. Literature describing the frequencies and phenotypic and genotypic characteristics of isolates harboring multiple carbapenemase genes is limited. Using data collected from the Antimicrobial Resistance …

us (code pays fourni par la source)

13 citations Journal of Clinical Microbiology
Accès ouvert 2024 article OpenAlex

Descriptive analysis of targeted carbapenemase genes and antibiotic susceptibility profiles among carbapenem-resistant Acinetobacter baumannii tested in the Antimicrobial Resistance Laboratory Network—United States, 2017–2020

Sarah Sabour, Katie Bantle, Amelia Bhatnagar, J. Huang et autres

) carbapenemase genes. During 2017‒2020, 6,026 CRAB isolates from 45 states were tested for targeted carbapenemase genes; 1% (64 of 5,481) of CRAB tested for targeted class A and class B genes were positive, but 83% (3,351 of 4,041) of CRAB tested …

us (code pays fourni par la source)

11 citations Microbiology Spectrum
Accès ouvert 2023 article OpenAlex

2747. Aztreonam-Avibactam Susceptibility Testing Program for Metallo-β-Lactamase-Producing Enterobacterales collected through the Antimicrobial Resistance Laboratory Network, March 2019 to April 2023

Amelia Bhatnagar, Porscha Bumpus-White, Sarah Sabour, Janine Bodnar et autres

Abstract Background Metallo-β-lactamase-producing Enterobacterales (MBL-E) are a major public health concern as they cause infections with few effective treatment options. Aztreonam-avibactam (AZA) is a β-lactam/β-lactamase inhibitor combination agent in the drug development pipeline that is active against MBL-E. Though clinical studies are …

us (code pays fourni par la source)

0 citations Open Forum Infectious Diseases
Accès ouvert 2023 article OpenAlex

Antimicrobial Resistance Laboratory Network’s multisite evaluation of the ThermoFisher Sensititre GN7F broth microdilution panel for antimicrobial susceptibility testing

Amelia Bhatnagar, María-José Machado, Logan Patterson, Karen Anderson et autres

ABSTRACT In 2017, the Centers for Disease Control and Prevention (CDC) established the Antimicrobial Resistance Laboratory Network to improve domestic detection of multidrug-resistant organisms. CDC and four laboratories evaluated a commercial broth microdilution panel. Antimicrobial susceptibility testing using the Sensititre GN7F (ThermoFisher …

us (code pays fourni par la source)

4 citations Journal of Clinical Microbiology
Accès ouvert 2021 article OpenAlex

Extensively Drug-Resistant Carbapenemase-Producing Pseudomonas aeruginosa and Medical Tourism from the United States to Mexico, 2018–2019

Ian Kracalik, D. Cal Ham, Gillian McAllister, Amanda R. Smith et autres

Carbapenem-resistant Pseudomonas aeruginosa (CRPA) producing the Verona integron‒encoded metallo-β-lactamase (VIM) are highly antimicrobial drug-resistant pathogens that are uncommon in the United States. We investigated the source of VIM-CRPA among US medical tourists who underwent bariatric surgery in Tijuana, Mexico. Cases were defined …

us, mx (code pays fourni par la source)

19 citations Emerging infectious diseases
Accès ouvert 2021 article OpenAlex

Carbapenemase production among less-common Enterobacterales genera: 10 US sites, 2018

Alicia Shugart, Garrett Mahon, J. Huang, Maria Karlsson et autres

Abstract Background Historically, United States’ carbapenem-resistant Enterobacterales (CRE) surveillance and mechanism testing focused on three genera: Escherichia, Klebsiella, and Enterobacter (EsKE); however, other genera can harbour mobile carbapenemases associated with CRE spread. Objectives From January through May 2018, we conducted a 10 …

us (code pays fourni par la source)

14 citations JAC-Antimicrobial Resistance
Accès ouvert 2021 article OpenAlex

Aztreonam-Avibactam Susceptibility Testing Program for Metallo-Beta-Lactamase-Producing Enterobacterales in the Antibiotic Resistance Laboratory Network, March 2019 to December 2020

Amelia Bhatnagar, Sandra Boyd, Sarah Sabour, Janine Bodnar et autres

Aztreonam-avibactam is a drug combination pending phase 3 clinical trials and is suggested for treatment of severe infections caused by metallo-beta-lactamase (MBL)-producing Enterobacterales by combining ceftazidime-avibactam and aztreonam. Beginning in 2019, four Antibiotic Resistance Laboratory Network regional laboratories offered aztreonam-avibactam susceptibility testing …

us (code pays fourni par la source)

32 citations Antimicrobial Agents and Chemotherapy
Accès ouvert 2021 article OpenAlex

Performance Evaluation of Serial SARS-CoV-2 Rapid Antigen Testing During a Nursing Home Outbreak

Susannah L. McKay, Farrell A. Tobolowsky, Erin D. Moritz, Kelly M Hatfield et autres

BACKGROUND: To address high COVID-19 burden in U.S. nursing homes, rapid SARS-CoV-2 antigen tests have been widely distributed in those facilities. However, performance data are lacking, especially in asymptomatic people. OBJECTIVE: To evaluate the performance of SARS-CoV-2 antigen testing when used for …

us (code pays fourni par la source)

67 citations Annals of Internal Medicine
Accès ouvert 2021 article OpenAlex

A Comparison of Less Invasive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Diagnostic Specimens in Nursing Home Residents—Arkansas, June–August 2020

Paige Gable, J. Huang, Sarah Gilbert, Susan Bollinger et autres

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing remains essential for early identification and clinical management of cases. We compared the diagnostic performance of 3 specimen types for characterizing SARS-CoV-2 in infected nursing home residents. METHODS: A convenience sample of 17 …

us (code pays fourni par la source)

7 citations Clinical Infectious Diseases

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.